Search

Search Constraints

You searched for: Author/Creator Cecchi, Fabiola

Search Results

1. 31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016): part one. Issue 1 (November 2016)

2. 31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016): part one. Issue 1 (November 2016)

3. 31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016): part one: National Harbor, MD, USA. 9-13 November 2016. (16th November 2016)

5. Association of high TUBB3 with resistance to adjuvant docetaxel-based chemotherapy in gastric cancer: translational study of ITACA-S. Issue 2 (April 2021)

6. Author Correction: Targeting wild-type KRAS-amplified gastroesophageal cancer through combined MEK and SHP2 inhibition. (October 2018)

8. High HER2 protein levels correlate with increased survival in breast cancer patients treated with anti‐HER2 therapy. Issue 1 (15th September 2015)

9. Imaging the Met Receptor Tyrosine Kinase (Met) and Assessing Tumor Responses to a Met Tyrosine Kinase Inhibitor in Human Xenograft Mouse Models with a [99mTc] (AH-113018) or CY 5** (AH-112543) Labeled Peptide. Issue 9 (1st September 2015)

10. MET activation confers resistance to cetuximab, and prevents HER2 and HER3 upregulation in head and neck cancer. Issue 3 (11th February 2019)